Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-02-27
2011-12-27
Chandrakumar, Nizal (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
08084625
ABSTRACT:
The present invention provides a crosslinking agent which have photodegradable protective groups at two ends to crosslink double-stranded nucleic acid, a nucleic acid and a protein or a polypeptide, or proteins or polypeptides, in particular, double-stranded RNA; a method for crosslinking a double-stranded RNA or the like using the same; a method for regulating gene expression, which can control the expression of a target gene at an arbitrary timing and location; and a method for examining a gene function.According to the present invention, crosslinking between double-stranded nucleic acids between a nucleic acid and a protein or a polypeptide, or between proteins or polypeptides, in particular, between double-stranded RNA can be easily formed, and in addition, the crosslinking can also be easily removed, so that the expression of a target gene can be easily controlled at an arbitrary timing and location with high efficiency. Hence, as a result, function examination and/or identification of a gene that is expressed at a specific timing and location can be performed. In addition, the RNAi effect of a double-stranded RNA (siRNA) that cannot be easily inhibited by a conventional caged compound can be inhibited, and the expression of a target gene can be easily controlled at an arbitrary timing and location.
REFERENCES:
patent: 2002/0155606 (2002-10-01), Okamoto et al.
patent: 2003/0143612 (2003-07-01), Ault-Riche et al.
patent: 2004/0053875 (2004-03-01), Kreutzer et al.
patent: 2004/0249178 (2004-12-01), Vargeese et al.
patent: 2002-315576 (2002-10-01), None
patent: 2003-502012 (2003-01-01), None
patent: WO 00/31588 (2000-06-01), None
patent: WO 0031588 (2000-06-01), None
patent: WO 2004/045547 (2004-06-01), None
Gao et al. STN Accession No. 1996:488342 , Abstract of Chinese Chemical Letters (1996), 7(8), 753-755.
Furrow et al. Journal of the American Chemical Society, 2004, 126, 12222-12223.
Ando et al.,Siekagaku, 75(9): 1251-1254 (2003).
Bernstein et al.,Nature, 409: 262-366 (2001).
Elbashir et al.,Genes&Dev., 15: 188-200 (2001).
Engels et al.,J. Med. Chem., 20(7): 907-911 (1977).
Fire et al.,Nature, 391: 806-811 (1998).
Givens et al.,Tetrahedron Letters, 37(35): 6259-6262 (1996).
Kaplan et al.,Biochemistry, 17(10): 1929-1935 (1978).
Ordoukhanian et al.,Bioconjugate Chem., 11(1): 94-103 (2000).
Park et al.,J. Am. Chem. Soc., 119: 2453-2463 (1997).
Svoboda et al.,Development, 127: 4147-4156 (2000).
Takaoka et al.,Bioorg. Med. Chem., 12(13): 3687-3694 (2004).
Zamore et al.,Cell, 101: 25-33 (2000).
Furuta Toshiaki
Imaizumi Natsuyo
Chandrakumar Nizal
Leydig , Voit & Mayer, Ltd.
Wako Pure Chemical Industries Ltd.
LandOfFree
Crosslinking agent, crosslinking method, method of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crosslinking agent, crosslinking method, method of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crosslinking agent, crosslinking method, method of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268712